TNF signaling drives myeloid-derived suppressor cell accumulation

Xueqiang Zhao(Chinese Academy of Sciences), Lijie Rong(Chinese Academy of Sciences), Xiaopu Zhao(Chinese Academy of Sciences), Xiao Li(Chinese Academy of Sciences), Xiaoman Liu(Chinese Academy of Sciences), Jingjing Deng(Chinese Academy of Sciences), Hao Wu(Chinese Academy of Sciences), Xia Xu(Chinese Academy of Sciences), Ulrike Erben(Chinese Academy of Sciences), Peihua Wu(Chinese Academy of Sciences), Uta Syrbe(Franklin University), Joachim Sieper(Franklin University), Zhihai Qin(Chinese Academy of Sciences)
Journal of Clinical Investigation
October 15, 2012
Cited by 372Open Access
Full Text

Abstract

TNF, an inflammatory cytokine that is enriched in the tumor microenvironment, promotes tumor growth and subverts innate immune responses to cancer cells. We previously reported that tumors implanted in TNF receptor-deficient (Tnfr-/-) mice are spontaneously rejected; however, the molecular mechanisms underlying this rejection are unclear. Here we report that TNF signaling drives the peripheral accumulation of myeloid-derived suppressor cells (MDSCs). MDSCs expand extensively during inflammation and tumor progression in mice and humans and can enhance tumor growth by repressing T cell-mediated antitumor responses. Peripheral accumulation of MDSCs was drastically impaired in Tnfr-/- mice. Signaling of TNFR-2, but not TNFR-1, promoted MDSC survival through upregulation of cellular FLICE-inhibitory protein (c-FLIP) and inhibition of caspase-8 activity. Loss of TNFRs impaired the induction of MDSCs from bone marrow cells, but this could be reversed by treatment with caspase inhibitors. These results demonstrate that TNFR-2 signaling promotes MDSC survival and accumulation and helps tumor cells evade the immune system.


Related Papers

No related papers found

Powered by citation graph analysis